Rapid development of glutathione-S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid

Cancer Letters

Volumn 136, Issue 1, 1999, Pages 47-52

  Caffrey, Paula B ^a   Zhu, Ming ^a   Zhang, Yixin ^a   Chinen, Norihiro ^a   Frenkel, Gerald D ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Drug resistance; Ethacrynic acid; Glutathione S transferase; Melphalan; Ovarian tumor cells

Indexed keywords

CISPLATIN; DOXORUBICIN; ETACRYNIC ACID; GLUTATHIONE TRANSFERASE; MELPHALAN; MESSENGER RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY TUMOR; PRIORITY JOURNAL; TUMOR CELL;

ANTINEOPLASTIC AGENTS, ALKYLATING; BLOTTING, NORTHERN; DRUG RESISTANCE, NEOPLASM; ETHACRYNIC ACID; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; MELPHALAN; OVARIAN NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0033001563     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00307-3     Document Type: Article

References (16)

1. Ayash L.J., Herman T.S., Frei E. Cancer chemotherapy: clinical evidence for drug resistance. Teicher B. Drug Resistance and Oncology. 1993;Marcel Dekker, New York.
2. Caffrey P.B., Frenkel G.D. The development of drug resistance by tumor cells in vitro is accompanied by the development of sensitivity to selenite. Cancer Lett. 81:1994;59-65.
3. Tew K.D., Houghton P.J., Houghton J.A. Preclinical and Clinical Modulation of Anticancer Drugs. 1993;CRC Press, Boca Raton, FL. pp. 13-77.
4. Bellamy W.T. The role of glutathione S-transferases in drug resistance. Kellen J.A. Alternative Mechanisms of Multidrug Resistance in Cancer. 1995;31 Birkhauser, Basle.
5. Ahokas J.T., Davies C., Ravenscroft P.J. Emmerson, B.T., Inhibition of soluble glutathione S-transferase by diuretic drugs. Biochemical Pharmacol. 33:1984;1929-1932.
6. Ploemen J.H., van Ommen B., van Bladeren P.J. Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate. Biochemical Pharmacol. 40:1990;1631-1635.
7. Tew K.D., Bomber A.M., Hoffman S.J. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res. 48:1988;3622-3625.
8. Hansson J., Berhane K., Castro V.M., Jungnelius U., Mannervik B., Ringborg U. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by glutathione transferase inhibitor ethacrynic acid. Cancer Res. 51:1991;94-98.
9. Hamilton T.C., Winker M.A., Louie K.A., Batist G. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug resistant and sensitive human ovarian tumor cells by buthionine sulfoximine mediated glutathione depletion. Biochemical Pharmacol. 34:1985;2583-2586.
10. Caffrey P.B., Frenkel G.D. Selenite cytotoxicity in drug resistant and non-resistant human ovarian tumor cells. Cancer Res. 52:1992;4812-4816.
11. Caffrey P.B., Frenkel G.D. Inhibition of cell colony formation by selenite: involvement of glutathione. Mol. Pharmacol. 39:1991;281-284.
12. Habig W.H., Jakoby W.B. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 77:1981;398-405.
13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
14. Gupta V., Singh S.V., Ahmad H., Medh R.D., Awasthi Y.C. Glutathione and glutathione S-transferases in a human plasma cell line resistant to melphalan. Biochem. Pharmacol. 38:1989;1993-2000.
15. Wang Y., Teicher B.A., Shea T.C., Holden S.A., Rosbe K.W., Al-Achi A., Henner W.B. Cross-resistance and glutathione S-transferase-π levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res. 49:1989;6185-6192.
16. Merlos M., Sanchez R.M., Camarasa J., Adzet T. Flavonoids as inhibitors of rat liver cytosolic glutathione S-transferase. Experientia. 47:1991;616-619.